MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
ImmunityBio, Inc. Common Stock

IBRX

#815
ImmunityBio, Inc. Common Stock
9.78
+3.93%
Sector:
Base:
Profit Currency:
Daily Range
9.78
9.78
Year Range
1.83
12.43
Daily Change
+3.93%
Monthly Change
+63.00%
6 month change
+312.66%
Year Change
+213.46%
Previous Close
9.41
Open
9.78
Bid
Ask
Low
9.78
High
9.78
Volume
189
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. IBRX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

News

Investing Investing
IBRX
2 days ago, 01:22
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
Investing Investing
IBRX
2026.02.26
ImmunityBio completes enrollment in bladder cancer trial
Benzinga Benzinga
IBRX
2026.02.26
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Investing Investing
BAC-PS MSFT ORCL AMAT AXON
2026.02.25
Netflix and Palantir among market cap stock movers on Wednesday
Benzinga Benzinga
IBRX
2026.02.25
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
Investing Investing
INTC ORCL AMZN EXPD HD
2026.02.24
AMD and Keysight Technologies among market cap stock movers on Tuesday
Investing Investing
C LLY WFC SCL TNDM
2026.02.23
Tesla, Oracle among market cap stock movers on Monday
Investing Investing
IBRX
2026.02.23
H.C. Wainwright raises Immunitybio stock price target to $15
Zacks Zacks
IBRX NTLA
2026.02.23
ImmunityBio (IBRX) Reports Q4 Loss, Beats Revenue Estimates
Investing Investing
C JPM-PL LLY ORCL EXPE
2026.02.23
American Express, Oracle among market cap stock movers on Monday
Investing Investing
IBRX
2026.02.23
Immunitybio Inc earnings beat by $0.05, revenue topped estimates
Benzinga Benzinga
IBRX
2026.02.23
ImmunityBio Shares Surge On 700% Revenue Growth Driven By Anktiva - ImmunityBio (NASDAQ:IBRX)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd